These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
692 related articles for article (PubMed ID: 17017486)
1. [Hormonal replacement therapy and selective estrogen receptor modulators in prevention of cardiovascular disease]. Kozakiewicz K; Wycisk A Wiad Lek; 2006; 59(5-6):377-82. PubMed ID: 17017486 [TBL] [Abstract][Full Text] [Related]
2. [Cardiovascular effects of selective estrogen receptor modulators. Current perspectives]. Simoncini T; Mannella P; Genazzani AR Recenti Prog Med; 2003 Feb; 94(2):51-6. PubMed ID: 12908369 [TBL] [Abstract][Full Text] [Related]
3. Comparative cardiovascular effects of different progestins in menopause. Rosano GM; Fini M Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197 [TBL] [Abstract][Full Text] [Related]
4. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases]. Higuchi T; Mizunuma H Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136 [TBL] [Abstract][Full Text] [Related]
5. Effects of estrogens and selective estrogen receptor modulators on indicators of cardiovascular health in postmenopausal women. Klein KP; Herrington DM Medscape Womens Health; 2002; 7(5):2. PubMed ID: 12466731 [No Abstract] [Full Text] [Related]
6. [Selective estrogen receptor modulators (SERMs) in the practice]. Nagykálnai T Magy Onkol; 2002; 46(2):165-75. PubMed ID: 12202896 [TBL] [Abstract][Full Text] [Related]
8. Hormone therapy and selective estrogen receptor modulators for prevention of coronary heart disease in postmenopausal women estrogen replacement from the cardiologist's perspective. Mobasseri S; Liebson PR; Klein LW Cardiol Rev; 2004; 12(6):287-98. PubMed ID: 15476565 [TBL] [Abstract][Full Text] [Related]
10. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated]. Emons G; Westphalen S MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648 [TBL] [Abstract][Full Text] [Related]
11. [Hormone replacement therapy and cardiovascular prevention. Where are we now?]. Lerman J; Siseles N Medicina (B Aires); 2008; 68(3):251-7. PubMed ID: 18689159 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular effects of raloxifene: the arterial and venous systems. Blumenthal RS; Baranowski B; Dowsett SA Am Heart J; 2004 May; 147(5):783-9. PubMed ID: 15131531 [TBL] [Abstract][Full Text] [Related]
13. Selective modulation of postmenopausal women: cutting the Gordian knot of hormone replacement therapy with breast carcinoma. Diamanti-Kandarakis E; Sykiotis GP; Papavassiliou AG Cancer; 2003 Jan; 97(1):12-20. PubMed ID: 12491500 [TBL] [Abstract][Full Text] [Related]
15. Chemoprevention of breast cancer. O'Regan RM Cancer Treat Res; 2000; 103():183-207. PubMed ID: 10948447 [No Abstract] [Full Text] [Related]
16. [Effects of estrogen and selective estrogen receptor modulators on osteoporosis]. Urano T Clin Calcium; 2005 Apr; 15(4):591-5. PubMed ID: 15802770 [TBL] [Abstract][Full Text] [Related]
17. The controversy over estrogen replacement therapy: an update on clinical trials. Gnatuk CL Curr Womens Health Rep; 2002 Apr; 2(2):89-94. PubMed ID: 12116607 [TBL] [Abstract][Full Text] [Related]
18. [Selective estrogen receptor modulators as a new concept in preventing health risks of menopause]. Vokrouhlická J; Pavo I; Stĕpán J Cas Lek Cesk; 1998 Nov; 137(22):679-85. PubMed ID: 9929934 [TBL] [Abstract][Full Text] [Related]
20. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]